The privately-owned company is a world leader in cancer care, providing support to relieve patients of the adverse side effects of cancer treatment. Helsinn manufactures and supplies active pharmaceutical ingredients and finished dosage forms, developing medical compounds for controlling various consequences in oncology and cancer supportive care, pain, inflammation, and gastrointestinal therapeutic areas. They are committed to making everything they do count towards improving the lives of people with cancer, from the products they choose to license to the quality standards they apply to manufacturing.